NEWPORT BEACH, Calif.--Acacia Research Corporation (Nasdaq:ACTG)(Nasdaq:CBMX) announced today that Acacia Patent Acquisition Corporation, a wholly owned subsidiary that is part of the Acacia Technologies group, a leader in technology licensing, has acquired rights to patents relating to purifying nucleic acids. “As Acacia’s licensing success grows, more companies are selecting us as their partner for the licensing of their patented technologies,” commented Paul Ryan, Acacia Chairman and CEO. “Acacia is rapidly becoming the leader in technology licensing and we continue to grow our base of future revenues by adding new patent portfolios,” concluded Mr. Ryan.
